Molecular modeling and molecular dynamics simulations of GPI 14 in \textit{Leishmania major}: insight into the catalytic site for active site directed drug design

DOI10.1016/J.JTBI.2014.02.017zbMATH Open1412.92179OpenAlexW2072437622WikidataQ46925671 ScholiaQ46925671MaRDI QIDQ2632813FDOQ2632813

Authors: Sonali Shinde, Milsee Mol, Virashree Jamdar, Shailza Singh 

Publication date: 15 May 2019

Published in: Journal of Theoretical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.jtbi.2014.02.017

Recommendations

• Modelling the activation of G-protein coupled receptors by a single drug
• Molecular modeling, simulation and virtual screening of ribosomal phosphoprotein P1 from \textit{Plasmodium falciparum}
• Modelling of the activation of G-protein coupled receptors: drug free constitutive receptor activity
• \textit{In silico} analysis of \textit{plasmodium falciparum} CDPK5 protein through molecular modeling, docking and dynamics

zbMATH Keywords

gene expressionphylogenycutaneous leishmaniasisdockingGPI biosynthesis

Mathematics Subject Classification ID

Medical epidemiology (92C60) Biochemistry, molecular biology (92C40)

Cited In (3)

• Molecular modeling, simulation and virtual screening of ribosomal phosphoprotein P1 from \textit{Plasmodium falciparum}
• Responses of a parasitic protozoan to osmotic stress
• \textit{In silico} analysis of \textit{plasmodium falciparum} CDPK5 protein through molecular modeling, docking and dynamics

Uses Software

• Gromacs
• MrBayes
• LINCS
• AutoDock Vina
• PyMOL
• SETTLE
• Q-SiteFinder

This page was built for publication: Molecular modeling and molecular dynamics simulations of GPI 14 in \textit{Leishmania major}: insight into the catalytic site for active site directed drug design

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2632813)